Effectiveness and Safety of Mobile Artificial Cervical Vertebrae Replacement for Patients With Cervical Spondylosis

Xi'an International Medical Center Hospital

Status: Unknown

Conditions: Cervical Spondylosis

Treatments: Procedure: mobile artificial cervical vertebrae replacement; Procedure: anterior cervical corpectomy and fusion

Study type: Interventional

Funder types: Other

Identifiers

NCT04813211

XianInternationalMCH_HXJ_02

Details and patient eligibility

About

The research team designed an artificial cervical joint prosthesis suitable for subtotal resection of the lower cervical vertebral body. Previous studies regarding cadaver and animal experiments have found that this artificial joint not only retains the normal range of physiological motion of the joint, but also has good stability. Preliminary studies have shown that the designed joints are sufficiently safe and stable. The titanium materials for joints have been verified for their toxicology in long-term clinical trials and have been monitored under relevant national testing agencies in China.

Full description

Artificial cervical disc technology has achieved certain clinical effects in the treatment of single-segment lesions of the lower cervical spine. However, simple artificial cervical disc replacement is only applicable for single-segment disc herniation, but not for two adjacent cervical segmental lesions, concurrent with vertebral hyperplasia and ossification of the posterior longitudinal ligament in the cervical spine. Traditional vertebral corpectomy and bone graft fusion can reduce the mobility of the cervical spine. Therefore, non-fusion fixation for such diseases has been a key issue to improve the efficacy of surgical treatments.

To this end, the research team designed an artificial cervical joint prosthesis suitable for subtotal resection of the lower cervical vertebral body. Previous studies regarding cadaver and animal experiments have found that this artificial joint not only retains the normal range of physiological motion of the joint, but also has good stability. Preliminary studies have shown that the designed joints are sufficiently safe and stable. The titanium materials for joints have been verified for their toxicology in long-term clinical trials and have been monitored under relevant national testing agencies in China.

To serve clinical patients faster and ensure that the trial design is safe, this study is designed to observe the effectiveness and safety of mobile artificial cervical vertebrae replacement for patients with cervical spondylosis.

Enrollment: 40 estimated patients

Sex: All

Ages: 18 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• (1)Age: 18-70 years, irrespective of sex;
• (2)For mobile artificial cervical vertebrae replacement, patients with cervical spondylosis who are planned to undergo anterior cervical corpectomy and resection of two adjacent intervertebral discs;
• (3)For anterior cervical corpectomy and fusion, patients with cervical spondylosis who are planned to undergo anterior cervical corpectomy and resection of two adjacent intervertebral discs;

Exclusion criteria

• (1) Patients who have participated in other clinical studies 3 months before the inception of the study;
• (2) Abnormalities in liver and kidney functions (aspartate aminotransferase, alanine aminotransferase, blood creatinine and urea nitrogen levels are 1.5 times higher than normal);
• (3) Obvious abnormalities in the blood system;
• (4) Abuse of drugs or ethanol;
• (5) Patients who have brain disorders, abnormal judging ability, or cannot cooperate with the observer;
• (6) Coronary heart disease or severe kidney disease;
• (7) Severe metabolic diseases and endocrine diseases that are out of drug control;
• (8) Pregnant and lactating women and couples who are about to become pregnant in the near future;
• (9) Severe lung diseases such as asthma and lung dysfunction;
• (10) Immunodeficiency;
• (11) Single-segment intervertebral disc herniation or compression;
• (12) 3 or more vertebral segments herniated or spinal cord compression due to ligament ossification;
• (13) Active infection (systemic or local cervical spine) or a history of local cervical spine infection;
• (14) A history of anterior cervical surgery;
• (15) Patients with a need for posterior surgical treatments, with severe arthritis of the cervical spine joint process, and with spinal cord compression on the back;
• (16) Severe osteoporosis;
• (17) Cervical vertebra deformity;
• (18) A history of ossification of the posterior longitudinal ligament of the cervical spine, ankylosing spondylitis, and heterotopic ossification;
• (19) Severe cervical spine instability or trauma to the posterior structure of the cervical spine, and cervical spondylolisthesis;
• (20) Abnormal soft tissues anterior to the cervical spine (tracheal or esophageal malformations, and a history of radiotherapy), and obesity;
• (21) Allergy to prosthetic materials;
• (22) Patients who have tumors that cannot be completely resected and patients who are predicted to suffer prosthetic loosening during survival time;
• (23) Other contraindications for surgery.

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

40 participants in 2 patient groups

Trial group

Experimental group

Description:

20 patients with cervical spondylosis undergoing mobile artificial cervical vertebrae replacement

Treatment:

Procedure: mobile artificial cervical vertebrae replacement

Control group

Experimental group

Description:

20 patients with cervical spondylosis undergoing anterior cervical corpectomy and fusion

Treatment:

Procedure: anterior cervical corpectomy and fusion